advertisement
Wu J 23
Showing records 1 to 23 | Display all abstracts from Wu J84731 Wireless, passive strain sensor in a doughnut-shaped contact lens for continuous non-invasive self-monitoring of intraocular pressure
M Kouhani MH
Lab on a chip 2020; 20: 332-342
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Wu J
Molecular Therapy 2020; 28: 820-829
84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Zhang X
Experimental Eye Research 2020; 190: 107892
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Wu J
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Zhang R
Experimental Eye Research 2020; 190: 107892
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Yu X
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Bell OH
Molecular Therapy 2020; 28: 820-829
84731 Wireless, passive strain sensor in a doughnut-shaped contact lens for continuous non-invasive self-monitoring of intraocular pressure
Wu J
Lab on a chip 2020; 20: 332-342
84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Chen J
Experimental Eye Research 2020; 190: 107892
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Copland DA
Molecular Therapy 2020; 28: 820-829
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Ping X
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
84731 Wireless, passive strain sensor in a doughnut-shaped contact lens for continuous non-invasive self-monitoring of intraocular pressure
Tavakoli A; Weber AJ
Lab on a chip 2020; 20: 332-342
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Young A
Molecular Therapy 2020; 28: 820-829
84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Wu J
Experimental Eye Research 2020; 190: 107892
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Xu X; Cui Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Pooley JR
Molecular Therapy 2020; 28: 820-829
84731 Wireless, passive strain sensor in a doughnut-shaped contact lens for continuous non-invasive self-monitoring of intraocular pressure
Li W
Lab on a chip 2020; 20: 332-342
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Yang H
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Maswood R; Evans RS
Molecular Therapy 2020; 28: 820-829
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Zhou J; Yin Q
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Khaw PT
Molecular Therapy 2020; 28: 820-829
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Shentu X
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
85021 Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Ali RR; Dick AD; Chu CJ
Molecular Therapy 2020; 28: 820-829
